Is Remedium Lifecare a good stock to invest in?

Remedium Lifecare can be analyzed on the following key metrics - TTM P/E: 42.53 Sector P/E: 22.85 Dividend Yield: 0% D/E ratio: -

Remedium Lifecare Share Price

Sector: Biotechnology & Drugs

Powered by

0.98 +0.03 (3.16%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 0.92

Today’s High 0.98

52 Week Low 0.80

52 Week High 15.13

Key Metrics

Market Cap (In Cr) 86.43
Beta 1.38
Div. Yield (%) 0
P/B 1.25
TTM P/E 42.53
Peg Ratio 1.37
Sector P/E 22.85
D/E 0.26
Open Price 0.95
Prev Close 0.91

View All Metrics

Remedium Lifecare Analysis

Price Analysis

1 Week

3.26%
3 Months

-25.22%
6 Month

-73.42%
YTD

-73.42%
1 Year

-90.85%

Risk Meter

51% Low risk
51% Moderate risk
51% Balanced Risk
51% High risk
51% Extreme risk

Remedium Lifecare News

₹10 Penny stock: Remedium Lifecare shares jump 5% as board to consider foreign currency bonds issue, acquisition

Premium

Remedium Lifecare shares up 5% as board to consider foreign currency bonds issue

1 min read . 28 Aug 2024

Remedium Lifecare share price today opened with an upside gap at ₹14.50 apiece and touched an intraday high of ₹16 per share. (Photo: Pixabay)

Premium

Remedium Lifecare share price jumps 11% after this order book update

1 min read . 29 Jul 2024

Remedium Lifecare board has declared bonus shares in 3:1 ratio fixing record date on 6th Juloy 2024 on ex-date basis. (Photo: Mint)

Premium

Remedium Lifecare share hits 20% upper circuit as stock trades ex-bonus today

2 min read . 05 Jul 2024

Remedium Lifecare stock rallied over 8% on Tuesday. (Pixabay)

Premium

Remedium Lifecare stock rises 8% as board mulls raising ₹200 crore via QIP

2 min read . 02 Jul 2024

View More News

Remedium Lifecare Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
405.25

Selling/ General/ Admin Expenses Total
0.76

Depreciation/ Amortization
0.04

Other Operating Expenses Total
7.45

Total Operating Expense
406.38

Operating Income
-1.13

Net Income Before Taxes
4.38

Net Income
2.13

Diluted Normalized EPS
0.03

Period
2024

Total Revenue
4041.71

Selling/ General/ Admin Expenses Total
2.23

Depreciation/ Amortization
0.06

Other Operating Expenses Total
4.8

Total Operating Expense
4008.46

Operating Income
33.25

Net Income Before Taxes
50.45

Net Income
32.73

Diluted Normalized EPS
0.57

Period
2023

Total Revenue
509.84

Selling/ General/ Admin Expenses Total
0.98

Depreciation/ Amortization
0.15

Other Operating Expenses Total
7.53

Total Operating Expense
502.52

Operating Income
7.32

Net Income Before Taxes
7.4

Net Income
5.43

Diluted Normalized EPS
0.09

Period
2022

Total Revenue
504.79

Selling/ General/ Admin Expenses Total
0.53

Depreciation/ Amortization
0.07

Other Operating Expenses Total
4.08

Total Operating Expense
503.16

Operating Income
1.63

Net Income Before Taxes
1.53

Net Income
1.08

Diluted Normalized EPS
0.02

Period
2021

Total Revenue
90.03

Selling/ General/ Admin Expenses Total
0.19

Depreciation/ Amortization
0.06

Other Operating Expenses Total
1.39

Total Operating Expense
89.38

Operating Income
0.65

Net Income Before Taxes
0.65

Net Income
0.48

Diluted Normalized EPS
0.01

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Remedium Lifecare Technical

Moving Average SMA

5 Day0.89
10 Day0.93
20 Day1.14

50 Day1.5
100 Day1.74
300 Day3.26

Remedium Lifecare Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Achyut Healthcare
3.64
-0.01
-0.27
6.25
2.82
85.75

Sunil Healthcare
82.76
0
0
104
60.55
84.88

Remedium Lifecare
0.98
0.03
3.16
15.13
0.8
86.43

Biofil Chemicals And Pharma
47
-0.4
-0.84
92
40.5
75.04

Vivo Bio Tech
37.1
-0.14
-0.38
56.9
31.2
59.83

Remedium Lifecare Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-May-25
Audited Results

24-Apr-25
Others

07-Apr-25
Rights issue of Equity Shares

14-Feb-25
Quarterly Results

22-Jan-25
Others

14-Nov-24
Quarterly Results

14-Aug-24
Quarterly Results

08-Aug-24
Quarterly Results

20-Jul-24
Increase in Authorised Capital

08-Jul-24
Others

Meeting Date
Announced on
Purpose

29-Apr-25
27-Mar-25
POM

02-Apr-25
03-Mar-25
POM

24-Jan-25
24-Dec-24
POM

26-Aug-24
26-Jul-24
POM

26-Jun-24
31-May-24
AGM

12-Feb-24
10-Jan-24
POM

20-Jul-23
26-Jun-23
AGM

Announced on
Record Date
Ex-Bonus
Description

27-May-24
06-Jul-24
05-Jul-24
Bonus issue of equity shares in the ratio of 3:1 of Rs. 10/-.

23-Jun-23
29-Jul-23
28-Jul-23
Bonus issue of equity shares in the ratio of 9:5 of Rs. 10/-.

Ex-Splits
Old FV
New FV
Description

23-Feb-24
5
1
Stock split from Rs. 5/- to Re. 1/-..

01-Sept-23
10
5
Stock split from Rs. 10/- to Rs. 5/-.

Announced on
Record Date
Ex-Rights Date
Ratio
FV
Premium
Description

22-Jan-25
15-Apr-25
15-Apr-25
61:50
1
0
Rights issue of equity shares of Re. 1/- in the ratio of 61:50 @ par

View All

Company Profile

ABOUT Remedium Lifecare

Industry Biotechnology & Drugs
ISIN INE549S01036
BSE Code 539561

Remedium Lifecare Limited is a pharmaceutical company, which is aligned across two business verticals, such as Products and Services. Products business comprises the trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovators and generic pharmaceutical players in both domestic and international markets, including the regulated markets. It is engaged in the business of trading in Advanced Pharmaceutical Intermediates, API’s and other pharma products used, including Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine, Ethyl Acetate, Hydrazine Hydrate, IPA, Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide. It also manufactures various APIs, such as Atorvastatin Calcium (Amorphous), Citalopram Hydrochloride and others.

MANAGEMENT

Ashish Parkar Chief Financial Officer
Kapil Goplani Chief Compliance Officer, Company Secretary
Adarsh Munjal Whole Time Director

REMEDIUM LIFECARE SUMMARY

Remedium Lifecare is trading 3.16% upper at Rs 0.98 as compared to its last closing price. Remedium Lifecare has been trading in the price range of 0.98 & 0.92. Remedium Lifecare has given -73.42% in this year & 3.26% in the last 5 days.

Remedium Lifecare has TTM P/E ratio 42.53 as compared to the sector P/E of 22.85.

The company posted a net profit of -2.05 Crores in its last quarter.

Listed peers of Remedium Lifecare include Achyut Healthcare (-0.27%), Sunil Healthcare (0%), Remedium Lifecare (3.16%) etc.

Remedium Lifecare has a 1.11% promoter holding & 98.89% public holding.

FAQs about Remedium Lifecare

Remedium Lifecare is trading at 0.98 as on 30 Jun, 2025 11:39:16 AM. This is 3.16% upper as compared to its previous closing price of 0.91

The market capitalization of Remedium Lifecare is 86.43 Cr as on 30 Jun, 2025 11:39:16 AM.

The 52 wk high for Remedium Lifecare is 15.13 whereas the 52 wk low is 0.80

Remedium Lifecare can be analyzed on the following key metrics -

TTM P/E: 42.53
Sector P/E: 22.85
Dividend Yield: 0%
D/E ratio: -

Remedium Lifecare reported a net profit of 2.13 Cr in 2025.

Remedium Lifecare Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Remedium Lifecare Share Price

Price Range

Key Metrics

Remedium Lifecare Analysis

Remedium Lifecare News

Remedium Lifecare shares up 5% as board to consider foreign currency bonds issue

Remedium Lifecare share price jumps 11% after this order book update

Remedium Lifecare share hits 20% upper circuit as stock trades ex-bonus today

Remedium Lifecare stock rises 8% as board mulls raising ₹200 crore via QIP

Remedium Lifecare Financials

Forecast

Forecast

Forecast

Remedium Lifecare Technical

Remedium Lifecare Peers

Remedium Lifecare Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Remedium Lifecare

MANAGEMENT

REMEDIUM LIFECARE SUMMARY

FAQs about Remedium Lifecare

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue